Table 3.
Laboratory diagnoses | No. diagnosed/no. tested | No. HIV co-infecteda | Any CXF abnormality n (%b) | Any opacity n (%b) | Nodules n (%b) | Pleural effusion n (%b) | Cavitation n (%b) | Lymphadenopathy n (%b) |
---|---|---|---|---|---|---|---|---|
HIV infection | 55 / 247 | -- | 32 (58.2) | 30 (54.5) | 1 (1.8) | 1 (1.8) | -- | 4 (7.3) |
SFGR | 13 / 141 | 2 (15.4) | 5 (38.5) | 5 (38.5) | -- | -- | -- | 1 (7.7) |
Leptospira spp. | 10 / 145 | 3 (33.3) | 3 (30) | 3 (30) | -- | -- | -- | 1 (10) |
Coxiella burnetii | 3 / 142 | 1 (33.3) | 1 (33.3) | -- | -- | -- | -- | -- |
Plasmodium spp. | 3 / 245 | 0 (0) | 1 (33.3) | 1 (33.3) | -- | -- | -- | -- |
Cryptococcus neoformans | 1 / 246 | 1 (100) | -- | -- | -- | -- | -- | -- |
Brucella spp. | 2 / 147 | 0 (0) | 1 (50) | 1 (50) | -- | -- | -- | -- |
Histoplasma capsulatum | 1 / 175 | 0 (0) | -- | -- | -- | -- | -- | -- |
Streptococcus pneumoniae | 1 / 246 | 1 (100) | -- | -- | -- | -- | -- | -- |
Percent (%) based on number HIV-infected diagnosed with condition (co-infection) by total number diagnosed.
Percent (%) based on number with specific abnormality by number of diagnosed with condition.
HIV, human immunodeficiency virus; SFGR, spotted fever group rickettsioses.